Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Singapore Institute Of Advanced Medicine HoldingsSGX:9G2 +3.45% Return-on-Tangible-Equity is -48.14% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 578 Healthcare Providers & Services companies, Singapore Institute Of Advanced Medicine Holdings ranks worse than 85.99% on this metric.
SGX:9G2's Return-on-Tangible-Equity is ranked worse than 85.99% of 578
companies
in the Healthcare Providers & Services industry
Industry Median: 10.7
vs SGX:9G2: -27.78
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Singapore Institute Of Advanced Medicine Holdings Return-on-Tangible-Equity Related Terms
Singapore Institute Of Advanced Medicine Holdings Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singapore Institute Of Advanced Medicine Holdings Return-on-Tangible-Equity Chart
Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend
Jun21
Jun22
Jun23
Jun24
Jun25
Return-on-Tangible-Equity
-15.80
-21.96
-36.54
-59.14
-39.39
Singapore Institute Of Advanced Medicine Holdings Quarterly Data
SGX:9G2 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singapore Institute Of Advanced Medicine Holdings Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -48.14% mean?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a Return-on-Tangible-Equity of -48.14% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. According to the industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #497 out of 578 companies in the Healthcare Providers & Services industry, placing it in the top 86%.
Is Singapore Institute Of Advanced Medicine Holdings' Return-on-Tangible-Equity too high?
Singapore Institute Of Advanced Medicine Holdings' current Return-on-Tangible-Equity is -48.14%. Based on the distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #497 out of 578 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Singapore Institute Of Advanced Medicine Holdings' Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #497 out of 578 companies for Return-on-Tangible-Equity. This places Singapore Institute Of Advanced Medicine Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.70, based on 578 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Institute Of Advanced Medicine Holdings's current Return-on-Tangible-Equity is -48.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current Return-on-Tangible-Equity of -48.14%. The current Return-on-Tangible-Equity is -48.14%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current Return-on-Tangible-Equity is -48.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:9G2 has been successfully added to your 
